期刊文献+

脓毒症研究中的问题与思考 被引量:3

原文传递
导出
摘要 近十多年来,脓毒症预后虽明显改善,但迄今仍是危重伤和各种危重病的主要死因,其病死率可达25%~30%,伴有休克时高达40%~50%。为此,脓毒症日益受到重视。PubMed数据库结果显示,1986—1995年共有10000余篇关于脓毒症的文献,2006—2015年论文数达到26835篇,增加了2.5倍。
出处 《中华创伤杂志》 CAS CSCD 北大核心 2016年第10期870-874,共5页 Chinese Journal of Trauma
基金 国家科技支撑计划(2012BAI11B01) 全军医学科技“十二五”重大项目(AWS14C003,AWS14C001-07)
  • 相关文献

参考文献19

  • 1Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness : the intensive care over nations (ICON) audit[J]. Lancet Respir Med, 2014, 2 (5) : 380-386. DOI:IO. 1016/$2213-2600(14)70061-X.
  • 2Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992, 101(6):1644-1655. DOI:IO. 1378/ chest. 101.6. 1644.
  • 3Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP / ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J]. Crit Care Med, 2003, 31 (4) : 1250-1256. DOI: 10. 1007/s00134-O03-1662-x.
  • 4Poeze M, Ramsay G, Gerlach H, et al. An international sepsis survey: a study of doctors' knowledge and perception about sepsis[J]. Crit Care, 2004, 8(6) :R409-R413. DOI:10. 1186/cc2959.
  • 5Vincent JL, Opal SM, Marshall JC, et al. Sepsis definitions: time for change[J]. Lancet, 2013, 381(9868):774-775. DOI:10. 1016/S0140-6736 ( 12)61815-7.
  • 6Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA, 2016, 315 (8) : 801-810. DOI: 10. 1001/jama. 2016. 0287.
  • 7Rosenthal VD, Maki DG, Mehta Y, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module[J].Am J In- fect Control, 2014, 42 ( 9 ) : 942-956. DOI: 10. 1016/j. ajie. 2014.05. 029.
  • 8Bochud PY, Bonten M, Marchetti O, et al. Antimierobial therapy for patients with severe sepsis and septic shock : an evidence-based review[ J]. Crit Care Med, 2004, 32 ( 11 Suppl) : $495-$512. DOI : 10. 1097/01. CCM. 0000143118. 41100.14.
  • 9Adhikari NK, Fowler RA, Bhagwanjee S, et al. Critical care and the global burden of critical illness in adults[ J]. Lancet, 2010, 376(9749) :1339-1346. DOI:10. 1016/S0140-6736(10)60446-1.
  • 10Fleischmann C, Scherag A, Adhikari NK, et al. Global burden of sepsis: a systematic review[J]. Crit Care, 2015, 19 Suppl 1 : 1-201. DOI:10. 1186/CC14101.

二级参考文献45

  • 1文爱清,蒋建新,朱佩芳,冯凯.重庆人群IL-1β启动子区-31、-511、-1470单核苷酸多态性位点间的连锁不平衡分析[J].中华医学遗传学杂志,2004,21(4):412-414. 被引量:6
  • 2Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin -6 gene on IL -6 transcription and plasma IL- 6 levels, and an association with systemic -onset juvenile chronic arthritis. J Clin Invest, 1998, 102:1369- 1376.
  • 3Schluter B, Rauthake C, Erren M, et al. Effect of the interleukin 6 promoter polymorphism (-174G/C) on the incidence and outcome of sepsis. Crit Care Med, 2002, 30:32 -37.
  • 4Warle MC, Farhan A, Metselaar HJ, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl, 2003,9 : 170 - 181.
  • 5McDaniel DO, Barber WH, Nguyan C, et al. Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in Mrican -American renal transplant patients.Transpl Immunol, 2003, 11 : 107 - 119.
  • 6Hsieh YY, Chang CC, Tsai FJ, et al. Association of an A allele for interleukin - 10 -627 gene promoter polymorphism with higher susceptibility to endometriosis. J Reprod Med, 2003, 48:735 -738.
  • 7Stassen NA, Leslie -Norfleet LA, Robertson AM, et al. Interferongamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery, 2002, 132:289 - 292.
  • 8Menges T, Hermans PW, Little SG, et al. Plasminogen - activatorinhibitor - 1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet, 2001, 357:1096 - 1097.
  • 9Menges T, Hermans PW, Little SG, et al. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet, 2001, 357:1096-1097.?A?A
  • 10Hubacek JA, Stuber F, Frohlich D, et al. Gene variants of the bac-tericidal/permeability increasing protein and lipopolysaccharide bind-ing protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med, 2001, 29:557-561.?A

共引文献7

同被引文献26

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部